MYX 0.66% $4.60 mayne pharma group limited

It appears the half yearly report has been very severe on the...

  1. 24 Posts.
    lightbulb Created with Sketch. 1
    It appears the half yearly report has been very severe on the sp. Projected EBITDA "no longer relevant" (which is essentially a profit downgrade); the delay releasing the new Doryx formulation; and high $AUD. With no update the stock is getting dumped.

    We need some good news!!! This is meant to be a good company.

    Interesting that one of the directors bought 1.5 m shares at 73c earlier this year.

    Any views?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.